Risk of Major Cardiovascular Events during Second-Line Antidiabetic Treatments: A Population-Based Cohort Study

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)555-556
JournalPharmacoepidemiology and Drug Safety
Volume24
DOIs
Publication statusPublished - 2015

Cite this